01 / NAICS Market Profile
NAICS 541714 Research And Development In Biotechnology (Except Nanobiotechnology) Federal Contracts
North American Industry Classification System code 541714
Federal contract activity classified under Research And Development In Biotechnology (Except Nanobiotechnology) across FY 2020–FY 2026. Net obligations include both new obligations and subsequent deobligations.
02 / Market Size
How large is the NAICS 541714 federal market?
03 / Spending Trend
NAICS 541714 contract spending by fiscal year
Annual obligations, activity, and participation across the same FY 2020–FY 2026 profile window.
Latest closed fiscal year$2.09B
FY 2026| Fiscal year | Obligations | Actions | Vendors | Customers | Change |
|---|---|---|---|---|---|
| FY 2020 | $2.06B | 1,617 | 587 | 36 | — |
| FY 2021 | $2.53B | 1,781 | 616 | 34 | +23.3% |
| FY 2022 | $2.81B | 2,049 | 723 | 34 | +10.8% |
| FY 2023 | $5.12B | 2,093 | 697 | 38 | +82.5% |
| FY 2024 | $3.86B | 2,418 | 701 | 39 | −24.7% |
| FY 2025 | $1.49B | 2,314 | 637 | 38 | −61.4% |
| FY 2026 | $2.09B | 1,829 | 548 | 35 | +40.5% |
04 / Top Federal Customers
Which federal agencies buy most in this industry?
Ranked by net obligations during FY 2020–FY 2026.
| Federal customer | Code | Obligations | Actions | Vendors | Market share |
|---|---|---|---|---|---|
| ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE | 7505 | $11.70B | 1,806 | 200 | 58.6% |
| MISSILE DEFENSE AGENCY (MDA) | 97JC | $3.48B | 253 | 6 | 17.5% |
| NATIONAL INSTITUTES OF HEALTH | 7529 | $1.97B | 4,049 | 454 | 9.9% |
| DEPT OF THE NAVY | 1700 | $752.74M | 965 | 153 | 3.8% |
| DEFENSE HEALTH AGENCY (DHA) | 97DH | $408.80M | 851 | 122 | 2.0% |
| DEFENSE ADVANCED RESEARCH PROJECTS AGENCY (DARPA) | 97AE | $333.95M | 580 | 66 | 1.7% |
| FOOD AND DRUG ADMINISTRATION | 7524 | $297.86M | 686 | 143 | 1.5% |
| DEPT OF THE ARMY | 2100 | $239.05M | 826 | 187 | 1.2% |
| DEFENSE THREAT REDUCTION AGENCY (DTRA) | 9761 | $130.48M | 403 | 43 | 0.7% |
| VETERANS AFFAIRS, DEPARTMENT OF | 3600 | $129.13M | 1,436 | 200 | 0.6% |
05 / Contracting Offices
Which contracting offices buy in NAICS 541714?
Ranked by net obligations during FY 2020–FY 2026.
| Office | Code | Agency | Obligations | Actions | Vendors | Market share |
|---|---|---|---|---|---|---|
| BARDA - ASPR / DAAPPO / BARDA DCMA | 75A501 | ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE | $11.69B | 1,799 | 200 | 58.6% |
| MISSILE DEFENSE AGENCY (MDA) | HQ0856 | MISSILE DEFENSE AGENCY (MDA) | $3.47B | 233 | 1 | 17.4% |
| NATIONAL INSTITUTES OF HEALTH NIAID | 75N930 | NATIONAL INSTITUTES OF HEALTH | $1.39B | 2,016 | 175 | 7.0% |
| DEF ADVANCED RESEARCH PROJECTS AGCY | HR0011 | DEFENSE ADVANCED RESEARCH PROJECTS AGENCY (DARPA) | $333.95M | 580 | 66 | 1.7% |
| NATIONAL INSTITUTES OF HEALTH NIDA | 75N950 | NATIONAL INSTITUTES OF HEALTH | $316.05M | 419 | 88 | 1.6% |
| NAVAL AIR SYSTEMS COMMAND | N00019 | DEPT OF THE NAVY | $298.77M | 25 | 1 | 1.5% |
| FDA OFFICE OF ACQ GRANT SVCS | 75F401 | FOOD AND DRUG ADMINISTRATION | $297.86M | 686 | 143 | 1.5% |
| ARMY MED RES ACQ ACTIVITY | HT9425 | DEFENSE HEALTH AGENCY (DHA) | $273.62M | 592 | 77 | 1.4% |
| NATIONAL INSTITUTES OF HEALTH NHLBI | 75N920 | NATIONAL INSTITUTES OF HEALTH | $134.18M | 281 | 64 | 0.7% |
| NIWC PACIFIC | N66001 | DEPT OF THE NAVY | $116.98M | 159 | 14 | 0.6% |
06 / Top Vendors
Which contractors lead the NAICS 541714 market?
| Vendor | Obligations | Actions | Customers | Market share | Latest activity |
|---|---|---|---|---|---|
| ADVANCED TECHNOLOGY INTERNATIONAL | $3.50B | 38 | 1 | 17.5% | Sep 30, 2026 |
| BOEING COMPANY, THE | $3.47B | 235 | 2 | 17.4% | May 11, 2026 |
| AMGEN USA INC. | $840.69M | 12 | 1 | 4.2% | Aug 4, 2026 |
| ALBERT B. SABIN VACCINE INSTITUTE, INC. (THE) | $551.53M | 41 | 1 | 2.8% | Sep 18, 2026 |
| SIGA TECHNOLOGIES, INC. | $549.00M | 18 | 1 | 2.8% | Aug 24, 2026 |
| MAPP BIOPHARMACEUTICAL, INC. | $399.67M | 77 | 3 | 2.0% | Sep 30, 2026 |
| ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC. | $395.43M | 80 | 4 | 2.0% | Sep 17, 2026 |
| TECHNICAL RESOURCES INTERNATIONAL, INC. | $393.49M | 67 | 2 | 2.0% | Sep 23, 2026 |
| PHARM-OLAM, LLC | $384.21M | 41 | 1 | 1.9% | Sep 28, 2026 |
| PPD DEVELOPMENT, L.P. | $339.95M | 58 | 4 | 1.7% | Sep 3, 2026 |
07 / Product and Service Mix
What products and services are purchased under NAICS 541714?
| PSC | Description | Obligations | Actions | Vendors | Share |
|---|---|---|---|---|---|
| AN42 | HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH | $4.57B | 364 | 55 | 22.9% |
| 1420 | GUIDED MISSILE COMPONENTS | $3.47B | 235 | 1 | 17.4% |
| AN13 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | $3.34B | 1,043 | 165 | 16.7% |
| AN11 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH | $2.39B | 2,783 | 248 | 12.0% |
| AN12 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $1.40B | 2,124 | 207 | 7.0% |
| 6505 | DRUGS AND BIOLOGICALS | $1.06B | 363 | 83 | 5.3% |
| AN14 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; R&D ADMINISTRATIVE EXPENSES | $314.70M | 325 | 75 | 1.6% |
| AC14 | NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; R&D ADMINISTRATIVE EXPENSES | $298.77M | 26 | 1 | 1.5% |
| AC12 | NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; APPLIED RESEARCH | $270.34M | 496 | 77 | 1.4% |
| AN41 | HEALTH R&D SERVICES; HEALTH CARE - OTHER; BASIC RESEARCH | $231.40M | 177 | 39 | 1.2% |
08 / Buying Pattern
How does the government buy in NAICS 541714?
| Common action type | Obligations | Actions |
|---|---|---|
| DEFINITIVE CONTRACT | $13.45B | 7,462 |
| DELIVERY ORDER | $6.34B | 3,467 |
| PURCHASE ORDER | $160.11M | 3,048 |
| BPA CALL | $4.58M | 124 |
09 / Recent Contract Awards
What was awarded most recently in NAICS 541714?
10 / Market Interpretation
How should contractors evaluate this market?
Start with the spending direction
Compare annual obligations with actions and vendor participation. Growth driven by only a few large actions represents a different opportunity from broad, recurring demand.
Follow the actual buyers
Move from federal customers to contracting offices. Offices reveal where acquisition responsibility and recurring purchasing activity are concentrated.
Measure accessible demand
Use competition, small-business participation, incumbent vendors, and PSC mix before treating the full $19.96B market as addressable.